Trial Profile
Phase II Study of RR110 in Patients With Active Crohn's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamibarotene (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 17 Apr 2014 New trial record
- 28 May 2008
- 25 May 2008